KARMA2 was an EEAST diabetes research study to explore whether ambulance clinicians could reliably and safely identify diabetic ketoacidosis using blood ketone meters, and start fluid therapy, and determine whether a full-scale clinical trial was warranted.
A summary of the initial KARMA2 findings can be found here.
The main KARMA2 conclusions were:
NEWS! These findings were presented at the 2023 Diabetes UK Professional Conference (April; Liverpool), where KARMA2 won the Diabetes UK Nursing and Allied Healthcare Professional Diabetes Research Award!
Next month, the results of the study interviews will be presented at the 999 EMS Research Forum (Manchester). The study team are also busy preparing papers for publication.
Published 16th May 2023